Influence of an absorbable alpha-glucosidase inhibitor (Bay o 1248) on the endocrine and exocrine pancreas of the rat.
The influence of an absorbable glucosidase inhibitor (Bay o 1248) on the endocrine and exocrine rat pancreas was evaluated. Rats fed a standard diet containing Bay o 1248 over 10 days consumed less food, gained about 30% less body weight than controls and showed meteorism. In these animals postprandial plasma insulin and glucose levels were decreased, but the total pancreatic insulin content was not different versus controls. The early insulin secretory response studied by pancreas perfusions was found reduced after a stimulatory glucose load (10 mM). Addition of the glucosidase inhibitor (1 mM) to the incubation medium diminished the glucose-induced insulin release from isolated islets of rats fed a standard diet. The compound added to the perfusion medium (10 microM) induced a slight reduction of half-maximal glucose-induced (10 mM) insulin release from the perfused pancreas. This inhibitory effect disappeared during maximal stimulation (20 mM glucose) of insulin secretion. The compound neither altered basal nor arginine-induced (15 mM) insulin release from the perfused organ. The exocrine pancreas was studied after feeding a Bay o 1248-enriched standard diet over 10 days. Amylase and trypsin concentration and total output into the biliary-pancreatic juice in response to CCK and secretin (20 IU or CU/kg body weight each) were diminished. The pancreatic enzyme content did not differ compared to controls. A significant role of carbohydrate maldigestion, systemic effects of the glucosidase inhibitor, and endocrine-exocrine pancreatic interrelations are discussed to account for the effects of the compound on the rat pancreas.